Old Web
English
Sign In
Acemap
>
authorDetail
>
Stephen Krause
Stephen Krause
Eisai
Medicine
Internal medicine
Amyloid
Oncology
Diabetes mellitus
4
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial): Clinical trial design and implementation
2020
Alzheimers & Dementia
Paul S. Aisen
Jin Zhou
Michael C. Irizarry
Lynn D. Kramer
Chad J. Swanson
Shobha Dhadda
Martin Rabe
Stephen Krause
David JianJun Li
Rema Raman
Michael C. Donohue
Gopalan Sethuraman
Keith A. Johnson
Reisa A. Sperling
Show All
Source
Cite
Save
Citations (2)
Amyloid burden assessed by three amyloid PET tracers in the elenbecestat MissionAD Phase 3 program: Neuroimaging / evaluating treatments
2020
Alzheimers & Dementia
Claire Roberts
June Kaplow
Monique Giroux
Stephen Krause
Michio Kanekiyo
Show All
Source
Cite
Save
Citations (0)
Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A–Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity
2019
Molecular Imaging and Biology
Shil Patel
Ashley Knight
Stephen Krause
Tyler Teceno
Cédric Tresse
Songye Li
Zhengxin Cai
Alexandra Gouasmat
Vincent Carroll
Olivier Barret
Vijay Gottmukkala
Wenjie Zhang
Xianhong Xiang
Thomas J. Morley
Yiyun Huang
Jan Passchier
Show All
Source
Cite
Save
Citations (14)
EVALUATION OF TAU DEPOSITION IN AMYLOID POSITIVE MCI OR MILD-AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [18 F]PI-2620 PET
2019
Alzheimers & Dementia
Andrew Stephens
Santiago Bullich
Andre Mueller
Mathias Berndt
Susan De Santi
David Scott
Kate Adamczuk
Joyce Suhy
June Kaplow
Stephen Krause
Julia Chang
Bruce Albala
Johan Luthman
Show All
Source
Cite
Save
Citations (0)
1